Comparing Two Ways to Take a Biopsy of Small Lung Nodules
Compares a needle biopsy through the skin with a robotic bronchoscope biopsy.
Plain-language title generated from the registry record
Registry title: A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
Key facts
- Where
- Basel, SwitzerlandSee the site
- Phase
- Phase 4
Where in Switzerland
- Basel University HospitalBasel, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Intuitive Surgical
- Trial code
- NCT07761351
- Record updated
- 25 September 2026
- Original description
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).Read full original descriptionShow less
A Randomized Controlled Trial Evaluating Lung Nodules - COMparing Percutaneous CT-Guided Biopsy And Shape-Sensing Robotic-Assisted Bronchoscopy (ENCOMPASS)
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).
Inclusion: Patient is aged 18 years or older at time of consent; Diagnostic nodule biopsy(s) indicated per multidisciplinary team (or equivalent); Target pulmonary nodule ≤2 cm in largest diameter; Patient is willing and able to give written informed consent for clinical study participation.
Exclusion: Patient has previously undergone a biopsy procedure of the target nodule by any approach; Patient was previously randomized in this study but did not undergo biopsy; Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results; Patient is pregnant or breastfeeding as determined by standard site practices; Patient lacks the capacity to provide informed consent for themselves, or is a vulnerable patient whose ability to protect their own interests or to consent freely may be diminished, including but not limited to, patients who may be unduly influenced through dependency on the sponsor, the hospital, or the study doctor; Patient is not willing to comply with study participation requirements.